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● Prior to matching, T had a preoperative IOP of 21.2±7.8 mmHg on 2.6±1.8 medications. 
After 1 year, the IOP had decreased to 15.9±4.2 and the number of medications 
decreased to 1.9±1.7.
● Prior to matching, BGI had a preoperative IOP of 20.4 ± 7.3 mmHg on 2.7±1.2 
medications.  After 1 year, the IOP decreased to 13.7±4.1 mmHg and the number of 
medications increased to 2.0±1.4.
● Matching resulted in 127 cases with at least 6 months of follow-up similar enough to 
justifiably compare.
● At 3 months, the difference in average IOP between BGI and T was insignificant at 0.8 ± 
1.2 mmHg (95% CI: -1.4 to 3.0 mmHg).
● At 6 months, BGI IOP was significantly lower by -2.7 ± 0.9 mmHg compared to T (95% CI: 
-4.4 to -1.1 mmHg).
● At 12 months, the BGI group has a significantly lower IOP by -3.2 ± 0.9 mmHg compared 
to T (95% CI: -5.0 to -1.5 mmHg).
Results
● Intraocular Pressure (IOP) outcomes for ab interno trabeculectomy with 
the Trabectome (T), a minimally invasive glaucoma surgery, have had 
relatively similar IOP results to trabeculectomy.[i,ii]  
● T rarely causes serious complications and has about 10 times less non-
serious complications compared to trabeculectomy or aqueous shunts and 
serious complications occur in <1%.[iii]
● Because of the above, we are now using T also in moderate to very 
advanced glaucoma for initial surgeries.
● No manuscript has yet compared IOP outcomes of T to Baerveldt 
Glaucoma Implants (BGI).
Background
● T and BGI had similar IOPs for the first 3 months.
● At 6 and 12 months, the IOP was significantly lower (2.7 and 3.2 mmHg 
respectively) following BGI in comparison to T.
● This further IOP decrease with BGI occurred despite a similar number of 
medications compared to T at 12 months (2.0 vs 1.9).
● The number of glaucoma medications dropped similarly between BGI and T 
at 12 months post-op (0.7 vs 0.7).
Discussion
● To compare the IOP reduction, number of medications, and complications  
after trabecular meshwork ablation with T vs trabecular bypass with the BGI.
Purpose
● After 6 months, BGI had a lower average IOP with a similar number of 
medications.
● BGI was able to maintain the significantly lower IOP through 12 months on a 
similar number of medications.
● Results of this study will allow informed design of RCTs or larger studies that 
can also match for medication strategies and justify crossover in case of 
failure.
● In this retrospective study of two glaucoma surgeries with well established, 
highly different profiles of complications, costs and length of procedure, BGI 
lowered IOP approximately 3.2 mmHg more than AIT in closely matched 
patient populations with similar a reduction of medications.
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# Months 
Postoperative
T, n T 
Postoperative 
IOP, mmHg
BGI, n BGI 
Postoperative 
IOP, mmHg
p-value
Preop 42  20.6±7.4 37 20.6±6.3 p>0.5
1 36 15.7±5.0 25 16.1±7.6 p>0.5
3 25 15.4±3.8 28 14.8±4.4 p>0.5
6 13 16.8±4.9 11 12.3±2.7 p<0.01
12 9 16.3±3.5 17 13.0±2.4 p<0.01
● Retrospective study of outcomes of T (n=94) to BGI (n=60) up to 1 year.
● Cases were matched with propensity-score matching using a genetic algorithm 
based on age, gender, type of glaucoma, concurrent phacoemulsification, and 
baseline IOP and number of glaucoma medications. Cases of T or BGI too 
different from their counterparts were excluded.
● Procedures were performed by the same group of surgeons on comparable 
patient populations for primary and secondary open angle glaucomas and chronic 
angle closure.
● Exclusion criteria consisted of neovascular glaucoma and <6 months of follow up
● IOP and number of medications were compared with a non-paired Student’s t-test 
and considered significant if p<0.05.
Methods
     Trabectome
● 1 year IOP ~ 15 mmHg
● fast, safe
● no permanent hardware
● needs clear cornea
● significant learning curve
BGI
● 1 year IOP ~ 13 mmHg
● non-valved = fast IOP drop
● tube can erode
● typically used for more advanced cases
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